Appointment of Independent Director - Bhaveshkumar Rajnikant Shah.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yash Chemex Limited's board, at its meeting on February 14, 2026, approved unaudited financial results for Q3 and 9M ended December 31, 2025. On a consolidated basis, total income for Q3 FY26 stood at Rs. 3,581.88 lakhs with a net profit of Rs. 114.35 lakhs; for the 9-month period, total income rose sharply to Rs. 10,511.56 lakhs (vs Rs. 6,631.53 lakhs in 9M FY25) and net profit grew to Rs. 291.52 lakhs (vs Rs. 239.42 lakhs). On a standalone basis, 9M FY26 net profit was largely flat at Rs. 127.74 lakhs versus Rs. 127.99 lakhs last year. The board also appointed Mr. Dhanik Jayeshkumar Mehta and Mr. Bhaveshkumar Rajnikant Shah as Additional Independent Directors for a 5-year term, subject to shareholder approval via postal ballot, along with reconstitution of the Audit, Nomination & Remuneration, and Stakeholders Relationship committees.
Consolidated 9-month revenue and profits show strong year-on-year growth, while standalone profits are flat—indicating the subsidiary (Yasons Chemex Care Ltd) is the primary growth driver. The new independent director appointments strengthen board composition, though these are routine governance changes unlikely to move the stock price materially.